The phase 3 trial was evaluating two doses of anti-LAG-3 antibody fianlimab in combination with PD-1 inhibitor Libtayo (cemiplimab) as a first-line treatment in more than 1,500 patients with unresectable locally advanced or metastatic melanoma, comparing the regimen to monotherapy with MSD's widely-used PD-1 drug Keytruda (pembrolizumab)
Our functional approach to weight loss injections prioritizes the overall health of someone without relying on a medication alone
The user then increases the dose every 4 weeks until reaching the maintenance dose of 7.2 mg
As little as one year off the drug was more than enough for study participants to lose benefits cultivated over years of continuous treatment
Chronic hyperglycemia mediated physiological alteration and metabolic distortion leads to organ dysfunction, infection, cancer progression and other pathophysiological consequences: An update on glucose toxicity
Tirzepatide (Mounjaro and Zepbound) may cause nausea, vomiting, diarrhea, constipation, indigestion, and stomach discomfort
